Metrion has invested in new laboratories, equipment, and staff, as part of the company's continued growth strategy to form strategic alliances and add "additional breadth."
A company that specialises in designing first-in-class small
molecule drugs that modulate ion channels has been given an award
for its innovative preclinical research.
Thanks to a small boy who couldn't feel pain, scientists have
discovered a gene mutation that opens the door to developing
powerful new drugs that could elimate all pain.
Cellectricon has launched a new chip for safety pharmacology and
hERG studies, which aims to provide a solution to the current need
for increased throughput and data quality in ion channel drug
discovery that has plagued drug researchers.
Sophion Bioscience and Physio-Tech have signed an agreement in
which Physio-Tech will become the exclusive distributor of Qpatch
16 systems in Japan, signifying its introduction into the Asian
market.